Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
183
Views
6
CrossRef citations to date
0
Altmetric
Original Research

The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients

Qing Song1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
,
Yi-Yang Zhao1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5975-8025View further author information
ORCID Icon,
Yu-Qin Zeng1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
,
Cong Liu1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
,
Wei Cheng1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1025-0591View further author information
ORCID Icon,
Min-Hua Deng4 Department of Respiratory, PLA Rocket Force Characteristic Medical Center, Beijing, 100088, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2741-7266View further author information
ORCID Icon,
Xin Li5 Division 4 of Occupational Disease, Hunan Occupational Disease Prevention and Treatment Hospital, Changsha, Hunan, 410000, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-5471-5808View further author information
ORCID Icon,
Li-Bing Ma6 Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, 541000, People’s Republic of ChinaView further author information
,
Yan Chen1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
,
Shan Cai1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaView further author information
&
Ping Chen1 Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, People’s Republic of China;2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of China;3 Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1401-1412 | Published online: 20 May 2021

References

  • Lareau SC, Fahy B, Meek P, Wang A. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2019;199(1):P1–P2. doi:10.1164/rccm.1991P1
  • Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
  • Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
  • Lee SJ, Yun SS, Ju S, et al. Validity of the GOLD 2017 classification in the prediction of mortality and respiratory hospitalization in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:911–919. doi:10.2147/COPD.S191362
  • Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
  • Soriano JB, Lamprecht B, Ramírez AS, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med. 2015;3(6):443–450. doi:10.1016/S2213-2600(15)00157-5
  • Goossens LM, Leimer I, Metzdorf N, Becker K, Rutten-van Molken MP. Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial. BMC Pulm Med. 2014;14:163. doi:10.1186/1471-2466-14-163
  • Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT study, Norway. Thorax. 2013;68(10):914–921. doi:10.1136/thoraxjnl-2013-203270
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary disease. N Engl J Med. 1999;340(25):1948–1953. doi:10.1056/NEJM199906243402503
  • Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebocontrolled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320(7245):1297–1303. doi:10.1136/bmj.320.7245.1297
  • Kim J, Yoon HI, Oh YM, et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1819–1827. doi:10.2147/COPD.S87766
  • Zhao YY, Liu C, Zeng YQ, et al. Modified and simplified clinically important deterioration: multidimensional indices of short-term disease trajectory to predict future exacerbations in patients with chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2020;14:1753466620977376. doi:10.1177/1753466620977376
  • Wei YF, Tsai YH, Wang CC, Kuo PH. Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan obstructive lung disease cohort. Int J Chron Obstruct Pulmon Dis. 2017;12:2723–2729. doi:10.2147/COPD.S138571
  • Duan JX, Cheng W, Zeng YQ, et al. Characteristics of patients with chronic obstructive pulmonary disease exposed to different environmental risk factors: a large cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2020;15:2857–2867. doi:10.2147/COPD.S267114
  • GOLD Executive Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2017 REPORT); Available from: https://goldcopd.org/. Accessed November, 2016.
  • Oishi K, Hirano T, Hamada K, et al. Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan. Int J Chron Obstruct Pulmon Dis. 2018;13:3901–3907. doi:10.2147/COPD.S181938
  • Olloquequi J, Jaime S, Parra V, et al. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respir Res. 2018;19(1):13. doi:10.1186/s12931-018-0718-y
  • Liu C, Cheng W, Zeng Y, et al. Different characteristics of ex-smokers and current smokers with COPD: a cross-sectional study in China. Int J Chron Obstruct Pulmon Dis. 2020;15:1613–1619. doi:10.2147/COPD.S255028
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
  • Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011;66(3):232–239. doi:10.1136/thx.2010.147884
  • Pathak U, Gupta NC, Suri JC. Risk of COPD due to indoor air pollution from biomass cooking fuel: a systematic review and meta-analysis. Int J Environ Health Res. 2020;30(1):75–88. doi:10.1080/09603123.2019.1575951
  • Cui Y, Dai Z, Luo L, Chen P, Chen Y. Classification and treatment of chronic obstructive pulmonary disease outpatients in China according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: comparison with GOLD 2014. J Thorac Dis. 2019;11(4):1303–1315. doi:10.21037/jtd.2019.03.99
  • Cabrera López C, Casanova Macario C, Marín Trigo JM, et al. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports. Impact on grouping and outcomes. Am J Respir Crit Care Med. 2018;197(4):463–469. doi:10.1164/rccm.201707-1363OC
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2011 [ cited May 5, 2012]. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed May 11, 2021.
  • Sadatsafavi M, McCormack J, Petkau J, Lynd LD, Lee TY, Sin DD. Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Eur Respir J. 2021;57(2).
  • Gedebjerg A, Szépligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018;6(3):204–212. doi:10.1016/S2213-2600(18)30002-X

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.